Robust EM Continual Reassessment Method in Oncology Dose Finding

Journal of the American Statistical Association - United Kingdom
doi 10.1198/jasa.2011.ap09476
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Continual Reassessment and Related Designs in Dose-Finding Studies

Statistics in Medicine
EpidemiologyStatisticsProbability
2011English

Continual Reassessment Method for Dose Escalation Clinical Trials in Oncology: A Comparison of Prior Skeleton Approaches Using AZD3514 Data

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Miscellanea. A Stopping Rule for the Continual Reassessment Method

Biometrika
StatisticsProbabilityUncertaintyApplied MathematicsBiological SciencesAgriculturalMathematics
1998English

A New Pragmatic Design for Dose Escalation in Phase 1 Clinical Trials Using an Adaptive Continual Reassessment Method

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Dose Finding Versus Speed in Seamless Immuno-Oncology Drug Development

Journal of Clinical Pharmacology
Pharmacology
2017English

Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

A Trivariate Continual Reassessment Method for Phase I/Ii Trials of Toxicity, Efficacy, and Surrogate Efficacy

Statistics in Medicine
EpidemiologyStatisticsProbability
2012English

Technology Assessment in Radiation Oncology: Time for Reassessment?

Nature Clinical Practice Oncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy